PLD2 and colorectal carcinoma: Only one report was found that high LAMP2A led to 5-FU resistance and enhanced PLD2 through NF-κB pathway activation, thereby promoting the proliferation, invasion, and anti-apoptotic functions of CRC drug-resistant cells (Xuan et al. 2021).